Eventide Asset Management LLC Boosts Stock Holdings in Mettler-Toledo International, Inc. $MTD

Key Points

• Eventide Asset Management LLC increased its holdings in Mettler-Toledo International, now owning 44,004 shares valued at approximately $51.96 million, marking a 10.3% rise during the first quarter.
• Mettler-Toledo's stock currently trades at $1,267.17, with a market capitalization of $26.10 billion and year-to-date earnings per share of $10.09, surpassing analysts' estimates.
• Major analysts have varied opinions on the stock, with recent price targets ranging from $1,200 to $1,600, reflecting a consensus rating of "Moderate Buy".

Eventide Asset Management LLC increased its position in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 10.3% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 44,004 shares of the medical instruments supplier's stock after acquiring an additional 4,097 shares during the period. Eventide Asset Management LLC owned approximately 0.21% of Mettler-Toledo International worth $51,963,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also modified their holdings of the company. Vanguard Group Inc. increased its holdings in shares of Mettler-Toledo International by 1.2% in the first quarter. Vanguard Group Inc. now owns 2,543,365 shares of the medical instruments supplier's stock valued at $3,003,485,000 after purchasing an additional 30,535 shares during the period. Alliancebernstein L.P. increased its holdings in shares of Mettler-Toledo International by 21.6% in the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier's stock valued at $837,653,000 after purchasing an additional 126,147 shares during the period. Price T Rowe Associates Inc. MD increased its holdings in shares of Mettler-Toledo International by 5.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier's stock valued at $568,032,000 after purchasing an additional 25,272 shares during the period. T. Rowe Price Investment Management Inc. increased its holdings in shares of Mettler-Toledo International by 11.9% in the first quarter. T. Rowe Price Investment Management Inc. now owns 406,189 shares of the medical instruments supplier's stock valued at $479,673,000 after purchasing an additional 43,082 shares during the period. Finally, GAMMA Investing LLC increased its holdings in shares of Mettler-Toledo International by 131,246.3% in the first quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier's stock valued at $456,018,000 after purchasing an additional 385,864 shares during the period. 95.07% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of the business's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the completion of the sale, the chief financial officer directly owned 5,095 shares in the company, valued at approximately $6,750,875. The trade was a 5.56% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Thomas P. Salice sold 1,062 shares of the business's stock in a transaction that occurred on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the sale, the director owned 283 shares of the company's stock, valued at approximately $368,154.70. This trade represents a 78.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 1,827 shares of company stock worth $2,371,208. Corporate insiders own 1.94% of the company's stock.

Mettler-Toledo International Price Performance

MTD stock traded up $8.67 during mid-day trading on Monday, reaching $1,314.38. 93,368 shares of the company's stock were exchanged, compared to its average volume of 170,729. The company has a market cap of $27.07 billion, a price-to-earnings ratio of 33.28, a price-to-earnings-growth ratio of 3.92 and a beta of 1.37. The stock's 50 day moving average is $1,251.17 and its 200 day moving average is $1,185.25. Mettler-Toledo International, Inc. has a 12-month low of $946.69 and a 12-month high of $1,521.01.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $9.58 by $0.51. The company had revenue of $983.22 million for the quarter, compared to the consensus estimate of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.Mettler-Toledo International's revenue for the quarter was up 3.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, research analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on MTD. Bank of America lifted their price objective on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a "neutral" rating in a research note on Thursday, June 26th. UBS Group upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and reduced their price objective for the company from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Citigroup lifted their price objective on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a research note on Thursday, August 21st. Barclays began coverage on Mettler-Toledo International in a research note on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 price objective for the company. Finally, Evercore ISI reduced their price objective on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating for the company in a research note on Monday, August 4th. Five research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat.com, Mettler-Toledo International presently has an average rating of "Moderate Buy" and a consensus target price of $1,311.11.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.